These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of β1integrin in normal epithelium, oral submucous fibrosis and oral squamous cell carcinoma. Veeravarmal V; Austin RD; Nagini S; Nassar MHM Pathol Res Pract; 2018 Feb; 214(2):273-280. PubMed ID: 29113685 [TBL] [Abstract][Full Text] [Related]
3. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study. Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271 [TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis. Choudhari S; Masne S; Bhandare P; Dhumal S J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762 [TBL] [Abstract][Full Text] [Related]
5. CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma. Silva LC; Fonseca FP; Almeida OP; Mariz BA; Lopes MA; Radhakrishnan R; Sharma M; Kowalski LP; Vargas PA Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e49-e55. PubMed ID: 31880289 [TBL] [Abstract][Full Text] [Related]
6. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis. Chaudhary M; Bajaj S; Bohra S; Swastika N; Hande A J Oral Maxillofac Pathol; 2015; 19(2):122-7. PubMed ID: 26604484 [TBL] [Abstract][Full Text] [Related]
7. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study. Sudha VM; Hemavathy S Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045 [TBL] [Abstract][Full Text] [Related]
8. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study. Kalaimani G; Rao UDK; Joshua E; Ranganathan K Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225 [TBL] [Abstract][Full Text] [Related]
9. Expression of Proliferating Cell Nuclear Antigen (PCNA) in Oral Submucous Fibrosis: An Immunohistochemical Study. Keshav R; Narayanappa U J Clin Diagn Res; 2015 May; 9(5):ZC20-3. PubMed ID: 26155556 [TBL] [Abstract][Full Text] [Related]
10. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity. Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759 [TBL] [Abstract][Full Text] [Related]
11. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis. Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of myofibroblasts in oral submucous fibrosis and oral squamous cell carcinoma: The pathogenesis and correlation. Gandhi P; Prasad UC Dent Res J (Isfahan); 2017; 14(5):314-320. PubMed ID: 29109745 [TBL] [Abstract][Full Text] [Related]
13. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis. Sarode SC; Sarode GS Med Hypotheses; 2013 Oct; 81(4):540-3. PubMed ID: 23891040 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. Sutariya RV; Manjunatha BS J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of extracellular matrix changes among oral submucous fibrosis and oral squamous cell carcinoma patients of Malwa region of Punjab using special histochemical stains: An insight into cancerous transformation. Gandhi P; Singh HP; Thippeswamy HS; Sodhi SPS; Kaur M; Laskar N J Oral Maxillofac Pathol; 2023; 27(3):600. PubMed ID: 38033958 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation. Angadi PV; Krishnapillai R Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review. Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571 [TBL] [Abstract][Full Text] [Related]
18. Expression of p63 and Proliferating Cell Nuclear Antigen in Oral Submucous Fibrosis. Suwasini S; Shrikaar M; Kumari N; Singh A; Kumari K; Kumar M J Int Soc Prev Community Dent; 2021; 11(4):448-456. PubMed ID: 34430507 [TBL] [Abstract][Full Text] [Related]